Pharmacokinetics of antifungal agent micafungin in critically ill patients receiving continuous hemodialysis filtration

Yakugaku Zasshi

Volumn 127, Issue 5, 2007, Pages 897-901

  Hirata, Kiyotaka ^a,b   Aoyama, Takahiko ^b   Matsumoto, Yoshiaki ^b   Ogawa, Futosi ^a   Yamazaki, Hiroshi ^c   Kikuti, Arimichi ^a   Yamamoto, Yasuhiro ^a  

^a NIPPON MEDICAL SCHOOL HOSPITAL   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Continuous hemodiafiltration; Critical care; Micafungin; Pharmacokinetics

Indexed keywords

MICAFUNGIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTINUOUS HEMODIAFILTRATION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG ISOLATION; FEMALE; HUMAN; INTENSIVE CARE UNIT; MALE;

ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CRITICAL ILLNESS; HEMODIAFILTRATION; HUMANS; INTENSIVE CARE UNITS; KIDNEY FAILURE, ACUTE; LIPOPROTEINS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC;

EID: 34247619753     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.127.897     Document Type: Article

References (17)

1. Bellomo R., Farmer M., Parkin G., Wright C., Boyce N., Nephron, 71, 59-64 (1995).
2. van Bommel E., Bouvy N. D., So K. L., Zietse R., Vincent H. H., Bruining H. A., Weimar W., Am. J. Nephrol., 15, 192-200 (1995).
3. Kishino S., Koshinami Y., Hosoi T., Suda N., Takekuma Y., Gandoh S., Furukawa H., Todo S., Miyazaki K., Ther. Drug Monit., 23, 4-8 (2001).
4. Vincent J. L., Bihari D. J., Suter P. M., Bruining H. A., White J., Nicolas-Chanoin M. H., Wolff M., Spencer R. C., Hemmer M., JAMA, 274, 639-644 (1995).
5. Nucci M., Colombo A. L., Silveira F., Richtmann R., Salomao R., Branchini M. L., Spector N., Infect. Control Hosp. Epidemiol., 19, 846-850 (1998).
6. Ueno H., Oda S., Kitamura N., Sadahiro T., Shiga H., Sugai T., Naiki K., Hikita S., Hirani T., Hirayama N., Hirayama Y., Hoshino T., Matsuda K., Moriguchi T., Yokohari K., Watanabe E., "Theoretical Consideration and Practice of CHDF," ed. by Hirasawa H., Sougouigaku, Inc., Tokyo, 2000, pp. 41-44.
7. Kishino S., Takekuma Y., Sugawara M., Shimamura T., Furukawa H., Todo S., Miyazaki K., J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 780(2), 289-294(2002).
8. Mukai T., Ohkuma T., Nakahara K., Takaya T., Uematsu T., Azuma J., Program and abstracts papers, the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (2001).
9. Astellas Pharma Inc., Fungard® for Infusion Package Insert Revised in June 2006 (11th edition).
10. Groll A. H., Walsh T. J., FK-463. Curr. Opin. Anti-infect. Investig. Drugs, 2, 405-412 (2000).
11. Tomishima M., Ohki H., Yamada A., Takasugi H., Maki H., Tawara S., Tanaka A., J. Antibiot., 52., 674-676 (1999).
12. Ikeda F., Nippon Ishinkin Gakkai Zasshi, 46, 217-222 (2005).
13. Lowrie L. H., Pediatr. Nephrol., 14, 6-12 (2000).
14. Joos B., Schmidli M., Keusch G., Nephrol. Dial. Transplant, 11, 1582-1585 (1996).
15. Golper T. A., Marx M. A., Kidney Int. Suppl., 66, S165-168 (1998).
16. Bugge J. F., Acta Anaesthesiol. Scand., 45, 929-934 (2001).
17. Yamato Y., Kaneko H., Hashimoto T., Katashima M., Ishibashi K., Kawamura A., Terakawa M., Kagayama A., Jpn. J. Chemother., 50, S-1, 74-79 (2002).